Your browser doesn't support javascript.
loading
Impact of DNA damage repair defects and aggressive variant features on response to carboplatin-based chemotherapy in metastatic castration-resistant prostate cancer.
Slootbeek, Peter H J; Duizer, Marleen L; van der Doelen, Maarten J; Kloots, Iris S H; Kuppen, Malou C P; Westgeest, Hans M; Uyl-de Groot, Carin A; Pamidimarri Naga, Samhita; Ligtenberg, Marjolijn J L; van Oort, Inge M; Gerritsen, Winald R; Schalken, Jack A; Kroeze, Leonie I; Bloemendal, Haiko J; Mehra, Niven.
Afiliação
  • Slootbeek PHJ; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Duizer ML; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • van der Doelen MJ; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Kloots ISH; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Kuppen MCP; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Westgeest HM; Institute for Medical Technology Assessment (iMTA), Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands.
  • Uyl-de Groot CA; Department of Internal Medicine, Amphia Hospital, Breda, The Netherlands.
  • Pamidimarri Naga S; Institute for Medical Technology Assessment (iMTA), Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands.
  • Ligtenberg MJL; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • van Oort IM; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Gerritsen WR; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Schalken JA; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Kroeze LI; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Bloemendal HJ; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Mehra N; Department of Experimental Urology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Int J Cancer ; 148(2): 385-395, 2021 01 15.
Article em En | MEDLINE | ID: mdl-32965028
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Prostata Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Reparo do DNA / Neoplasias de Próstata Resistentes à Castração Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Aged / Humans / Male País/Região como assunto: Europa Idioma: En Revista: Int J Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Prostata Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Reparo do DNA / Neoplasias de Próstata Resistentes à Castração Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Aged / Humans / Male País/Região como assunto: Europa Idioma: En Revista: Int J Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Holanda